SCHEMBL4567273

SCHEMBL4567273

CCC(COC)OC(C)=O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.42
TSHR P16473 2/20 0.39
LMNA P02545 2/20 0.37
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
HRH1 P35367 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ACACB O00763 2/20 0.37
TDP1 Q9NUW8 1/20 0.36
SLC18A3 Q16572 1/20 0.36
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM1 P11229 1/20 0.34
TBXA2R P21731 1/20 0.34
ALDH1A1 P00352 2/20 0.33
PGD P52209 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11172217 0.88 TSHR (0.43) PRKCATSHRLMNAMEN1CYP1A2
SCHEMBL12323575 0.84 PRKCA (0.51) PRKCATSHRLMNAMEN1CYP1A2
SCHEMBL1469728 0.84 ACACB (0.38) PRKCAMEN1KMT2AACACBALDH1A1
SCHEMBL2957512 0.84 PRKCA (0.51) PRKCATSHRLMNAMEN1CYP1A2
SCHEMBL1584634 0.83
SCHEMBL3801260 0.83 PRKCA (0.44) PRKCATSHRLMNAMEN1CYP1A2
SCHEMBL425452 0.82 TDP1 (0.50) PRKCATSHRLMNAMEN1CYP1A2
SCHEMBL1469110 0.82 ACACB (0.40) PRKCAMEN1KMT2AACACB
SCHEMBL5484842 0.82 MEN1 (0.35) PRKCAMEN1KMT2AACACBALDH1A1
SCHEMBL5192564 0.82 TDP1 (0.50) PRKCATSHRLMNAMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9849129-B2 Sodium channel blockers for skin disorders PARION SCIENCES, INC. (US) 2017-12-26 US disclosed
US-20170020870-A1 SODIUM CHANNEL BLOCKERS FOR SKIN DISORDERS PARION SCIENCES, INC. 2017-01-26 US disclosed
US-8778864-B2 Polyglyceryl compounds and compositions JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2014-07-15 US disclosed
US-8455418-B2 Polyglyceryl compounds comprising a methyl glucoside or sorbitan remnant and compositions containing same JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2013-06-04 US disclosed
US-8394755-B2 Polyglyceryl compounds and compositions JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2013-03-12 US disclosed
US-8211850-B2 Polyglyceryl compounds and compositions JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2012-07-03 US disclosed
US-20120122755-A1 POLYGLYCERYL COMPOUNDS AND COMPOSITIONS JOHNSON & JOHNSON CONSUMER INC. 2012-05-17 US disclosed
US-20120123103-A1 POLYGLYCERYL COMPOUNDS AND COMPOSITIONS KENVUE BRANDS LLC 2012-05-17 US disclosed
US-20120122758-A1 POLYGLYCERYL COMPOUNDS AND COMPOSITIONS KENVUE BRANDS LLC 2012-05-17 US disclosed
US-20120123104-A1 POLYGLYCERYL COMPOUNDS AND COMPOSITIONS KENVUE BRANDS LLC 2012-05-17 US disclosed
US-7858159-B2 Photocurable composition for sealant, liquid crystal sealant, and liquid crystal panel DAINIPPON INK AND CHEMICALS, INC. (JP) 2010-12-28 US disclosed
US-20090131550-A1 PHOTOCURABLE COMPOSITION FOR SEALANT, LIQUID CRYSTAL SEALANT, AND LIQUID CRYSTAL PANEL DAINIPPON INK AND CHEMICALS, INC. (JP) 2009-05-21 US disclosed
US-5128234-A PRODUCTION OF PHOTOPOLYMERIC FLEXOGRAPHIC RELIEF PRINTING PLATES BASF AKTIENGESELLSCHAFT (DE) 1992-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120123104-A1 POLYGLYCERYL COMPOUNDS AND COMPOSITIONS PHOSPHO1, SGMS1, SGMS2 PRKCA 2464/4885TSHR 4727/4885LMNA 705/4885
US-20120122755-A1 POLYGLYCERYL COMPOUNDS AND COMPOSITIONS PHOSPHO1, SGMS1, SGMS2 PRKCA 2464/4885TSHR 4727/4885LMNA 705/4885
US-20090131550-A1 PHOTOCURABLE COMPOSITION FOR SEALANT, LIQUID CRYSTAL SEALANT, AND LIQUID CRYSTAL PANEL TRPA1, ANXA1, ANXA11 PRKCA 4789/4885TSHR 4590/4885LMNA 1845/4885
US-20120122758-A1 POLYGLYCERYL COMPOUNDS AND COMPOSITIONS PHOSPHO1, SGMS1, SGMS2 PRKCA 2464/4885TSHR 4727/4885LMNA 705/4885
US-20120123103-A1 POLYGLYCERYL COMPOUNDS AND COMPOSITIONS PHOSPHO1, SGMS1, SGMS2 PRKCA 2464/4885TSHR 4727/4885LMNA 705/4885
US-20170020870-A1 SODIUM CHANNEL BLOCKERS FOR SKIN DISORDERS SCNN1B, SCNN1A, SCNN1G PRKCA 1361/4885TSHR 2482/4885LMNA 1264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.